MUC1 and combined pulmonary fibrosis-emphysema syndrome: We checked the clinical characteristics of the 46 patients with CPFE who visited our hospital and analyzed them to determine whether KL-6 and SP-D are useful biomarkers for CPFE, as they are for IPF.